Skip to content

Clinical trials

Phase 3 Stroke trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Switzerland Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20054
20064
20082
20101
20111
20121
20134
20142
20161
20171
20182
20192
20201
20212
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated10
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Boehringer Ingelheim3
Novartis Pharmaceuticals3
Pfizer2
University of Zurich2
AstraZeneca1
CSL Behring1
CoAxia1
Columbia University1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke34
Ischemic Stroke10
Myocardial Infarction9
Cardiovascular Diseases8
Atrial Fibrillation4
Ischemic Attack, Transient4
Coronary Artery Disease3
Hyperlipidemias3
Ischemia3
Peripheral Arterial Disease3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.